RPS welcomes NICE guidance on cannabis-based medicinal products

Welcoming new NICE guidance on cannabis-based medicinal products published today, RPS Chief Scientist Gino Martini said:

“It’s excellent news for patients that two cannabis-based medicines, Sativex and Epidyolex, for epilepsy and multiple sclerosis, have been approved for use by the NHS in England.

“Pharmacists will be on the frontline of supplying cannabis-based medicinal products and can give advice to patients on them as part of their treatment plan. It’s essential there is robust governance around prescribing and dispensing, and pharmacists have a key role to play in ensuring this is in place across health systems.”

“It’s also good to see that many of the recommendations we made to the draft NICE guidance have been taken on board.  “In particular, we welcome the recommendation that there is a focus on prescribing based on clinical evidence.

“It’s encouraging to see the detail around shared care in the guidance, balancing patient access with specialist expertise. The guideline recognises the need for clear lines of responsibility and that some non-specialist clinicians might not be comfortable prescribing. 

“We agree that national registers of treatment with cannabis-based medicinal products should be set up to record evidence on clinical outcomes and adverse effects with prescribing in real-life situations.”



Spread the cost of your membership


With the recent cost of living rises, we’re all making savings wherever we can – and you can do the same with your RPS membership.

Instead of paying for everything all at once, make life easier by paying monthly. After all, you use your RPS membership benefits all year round, so it makes sense to pay for them the same way.

With monthly Direct Debit, you only have a small, regular payment each month. It’s the easy way to keep practicing at your best, without making a hole in your finances!

Spread the cost of your membership - join by monthly Direct Debit today.